In a groundbreaking study published in the forefront journal Food Innovation and Advances on January 27, 2026, researchers from Shandong Agricultural University have uncovered pivotal insights into the molecular underpinnings of the anti-inflammatory potential inherent in dandelion polyphenols. Spearheaded by Hui Zou and Yilun Chen, this research elucidates how two bioactive compounds—quercetin and caffeic acid—serve as critical modulators of inflammatory signaling, particularly through their interaction with the advanced glycation end product (AGE) and its receptor (RAGE) pathway. This discovery not only amplifies the therapeutic promise of natural plant-derived substances but also paves a novel path toward the development of functional foods designed to combat diet-induced chronic inflammation and related metabolic disorders.
The exploration began with an integrative network pharmacology and molecular docking approach aimed at dissecting the complex bioactive landscape of Taraxacum officinale, commonly known as dandelion. Although dandelion has traditionally been prized for its medicinal and nutritional attributes, the exact molecular mechanisms through which its constituent polyphenols exert anti-inflammatory effects remained largely obscure. Leveraging advanced bioinformatics databases, the investigators meticulously screened 56 distinct bioactive compounds present within dandelion extracts to predict their potential interactions with key inflammation-related protein targets.
Out of the extensive compound library, eight candidates emerged prominently due to their predicted affinities for 29 inflammation-associated proteins. Among these, quercetin and caffeic acid stood out for their pronounced engagement with multiple pivotal targets within the AGE–RAGE signaling cascade. Molecular docking simulations revealed that quercetin exhibits robust binding affinities toward inflammatory mediators such as interleukin-1 beta (IL1B) and intercellular adhesion molecule 1 (ICAM1). In contrast, caffeic acid demonstrated a stronger binding propensity to tumor necrosis factor-alpha (TNF), indicating differentiated but complementary mechanisms for interrupting the transmission of inflammatory signals.
To transition from computational predictions to biological validation, the research team conducted cellular assays utilizing the THP-1 human monocyte-derived macrophage model. These immune cells were subjected to stimulation by AGEs to emulate chronic inflammatory conditions commonly observed in metabolic disease states. Treatment regimens incorporating variable ratios of quercetin and caffeic acid were administered, with subsequent quantification of key pro-inflammatory cytokines, namely TNF-α and IL-1β. Remarkably, both polyphenols individually mediated significant reductions in cytokine secretion relative to untreated controls, verifying their anti-inflammatory efficacy in vitro.
Further probing the combinatorial potential of these compounds, the researchers discovered a synergistic effect when quercetin and caffeic acid were applied in equal proportions. This enhanced inhibitory impact on cytokine production underscored the possibility of cooperative molecular interactions that amplify anti-inflammatory outcomes beyond the additive effects of single compounds. Such synergy holds substantial implications for designing nutraceutical formulations that maximize therapeutic benefits while minimizing required dosages.
Seeking to unravel gene- and protein-level changes underlying these observations, the investigators undertook comprehensive transcriptomic and proteomic analyses. This multi-omics approach spotlighted notable downregulation of critical genes implicated in inflammatory signaling, including ICAM1, IL1B, and thrombomodulin (THBD), following treatment with quercetin or the combined quercetin–caffeic acid regimen. Additionally, expression patterns of the chemokine CXCL8 were modulated, suggesting a broader influence on immune cell recruitment and inflammatory milieu remodeling. Quantitative PCR and Western blot assays corroborated these findings, affirming the robustness of the molecular data.
Additional molecular docking affirmed that quercetin and caffeic acid engage directly with RAGE, the receptor orchestrating AGE-mediated pro-inflammatory signaling. Importantly, the binding of these polyphenols appears to interfere downstream of the receptor’s activation, rather than competing directly with AGE ligands for the receptor’s canonical binding domain. This nuanced mechanism highlights an innovative mode of pharmacological modulation distinct from classical receptor blockade and opens avenues for selective attenuation of pathological signaling pathways.
By integrating cutting-edge computational analyses with experimental evidence from cell models and molecular assays, this study constitutes a comprehensive framework for understanding how natural polyphenols from dandelion can effectively regulate chronic inflammation at multiple biological scales. The identification of quercetin and caffeic acid as principal bioactive agents unlocks their potential as lead compounds in the emerging field of functional food development, with promising applications aimed at mitigating systemic inflammation induced by modern dietary patterns.
Given the escalating global prevalence of metabolic syndromes linked to chronic low-grade inflammation, the insights derived from this research assume critical public health significance. Incorporating dandelion-based polyphenolic compounds into everyday nutrition could offer a safe, accessible, and efficacious strategy to curtail inflammatory pathways implicated in diabetes, cardiovascular diseases, and other non-communicable conditions. Moreover, the elucidation of their molecular interactions within the AGE–RAGE axis enhances scientific understanding of how diet-derived phytochemicals modulate immune responses and metabolic homeostasis.
This work also exemplifies the power of integrating network pharmacology and multi-omics techniques in natural product research, enabling a more precise characterization of compound-target interactions and biological outcomes. The ability to map complex signaling pathways influenced by plant polyphenols advances both pharmacological discovery and functional food innovation, fostering translational applications that bridge traditional herbal knowledge with modern biomedicine.
Future research will undoubtedly delve deeper into the dose-dependent effects and pharmacokinetics of quercetin and caffeic acid in vivo, as well as explore their efficacy across diverse inflammatory conditions and populations. The potential for synergistic combinations involving additional dandelion-derived compounds also warrants exploration, as does the optimization of extraction and formulation techniques to ensure stability, bioavailability, and consumer acceptability.
In conclusion, this pioneering study illuminates the molecular intricacies through which dandelion polyphenols exert their anti-inflammatory actions via modulation of the AGE–RAGE pathway. By unlocking the therapeutic potential of quercetin and caffeic acid, it lays the scientific foundation for novel functional foods and nutraceutical products designed to address the burgeoning health challenges posed by chronic inflammation. Such interdisciplinary approaches are poised to revolutionize our capacity to harness nature’s pharmacopoeia toward enhancing human health and combating metabolic diseases linked to contemporary lifestyles.
Subject of Research: Not applicable
Article Title: Anti-inflammatory potential of dandelion polyphenols through modulation of AGE–RAGE signaling: key bioactive compounds and implications for functional foods
News Publication Date: 27-Jan-2026
References:
DOI: 10.48130/fia-0025-0053 (http://dx.doi.org/10.48130/fia-0025-0053)
Keywords:
Dandelion, Taraxacum officinale, Polyphenols, Quercetin, Caffeic acid, Anti-inflammatory, AGE–RAGE pathway, Cytokines, TNF-α, IL-1β, Functional foods, Nutraceuticals
